JPH0250885B2 - - Google Patents
Info
- Publication number
- JPH0250885B2 JPH0250885B2 JP5485281A JP5485281A JPH0250885B2 JP H0250885 B2 JPH0250885 B2 JP H0250885B2 JP 5485281 A JP5485281 A JP 5485281A JP 5485281 A JP5485281 A JP 5485281A JP H0250885 B2 JPH0250885 B2 JP H0250885B2
- Authority
- JP
- Japan
- Prior art keywords
- coating
- liquid
- fatty acid
- water
- acid ester
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 18
- 239000000194 fatty acid Substances 0.000 claims description 18
- 229930195729 fatty acid Natural products 0.000 claims description 18
- -1 sucrose fatty acid ester Chemical class 0.000 claims description 17
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
- 229930006000 Sucrose Natural products 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims description 14
- 239000005720 sucrose Substances 0.000 claims description 14
- 229920001577 copolymer Polymers 0.000 claims description 8
- 238000007720 emulsion polymerization reaction Methods 0.000 claims description 7
- JIGUQPWFLRLWPJ-UHFFFAOYSA-N Ethyl acrylate Chemical compound CCOC(=O)C=C JIGUQPWFLRLWPJ-UHFFFAOYSA-N 0.000 claims description 6
- CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 claims description 6
- 239000002702 enteric coating Substances 0.000 claims description 6
- 238000009505 enteric coating Methods 0.000 claims description 6
- PNJWIWWMYCMZRO-UHFFFAOYSA-N pent‐4‐en‐2‐one Natural products CC(=O)CC=C PNJWIWWMYCMZRO-UHFFFAOYSA-N 0.000 claims description 6
- 238000000576 coating method Methods 0.000 description 41
- 239000011248 coating agent Substances 0.000 description 40
- 239000007788 liquid Substances 0.000 description 36
- 239000008187 granular material Substances 0.000 description 14
- 229960004793 sucrose Drugs 0.000 description 13
- 238000002360 preparation method Methods 0.000 description 12
- 238000000034 method Methods 0.000 description 10
- 239000008213 purified water Substances 0.000 description 8
- 229920003138 Eudragit® L 30 D-55 Polymers 0.000 description 7
- GDCRSXZBSIRSFR-UHFFFAOYSA-N ethyl prop-2-enoate;2-methylprop-2-enoic acid Chemical compound CC(=C)C(O)=O.CCOC(=O)C=C GDCRSXZBSIRSFR-UHFFFAOYSA-N 0.000 description 7
- 238000003756 stirring Methods 0.000 description 7
- 238000012812 general test Methods 0.000 description 6
- 238000010998 test method Methods 0.000 description 6
- 239000004014 plasticizer Substances 0.000 description 5
- 150000002148 esters Chemical class 0.000 description 4
- 239000002904 solvent Substances 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 3
- 239000003960 organic solvent Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 238000006116 polymerization reaction Methods 0.000 description 3
- 229920000623 Cellulose acetate phthalate Polymers 0.000 description 2
- 229920003134 Eudragit® polymer Polymers 0.000 description 2
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 2
- BAPJBEWLBFYGME-UHFFFAOYSA-N Methyl acrylate Chemical compound COC(=O)C=C BAPJBEWLBFYGME-UHFFFAOYSA-N 0.000 description 2
- VVQNEPGJFQJSBK-UHFFFAOYSA-N Methyl methacrylate Chemical compound COC(=O)C(C)=C VVQNEPGJFQJSBK-UHFFFAOYSA-N 0.000 description 2
- 239000002202 Polyethylene glycol Substances 0.000 description 2
- 229920002472 Starch Polymers 0.000 description 2
- 229940081734 cellulose acetate phthalate Drugs 0.000 description 2
- 239000006185 dispersion Substances 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 150000004665 fatty acids Chemical class 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 210000004051 gastric juice Anatomy 0.000 description 2
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 2
- 230000000968 intestinal effect Effects 0.000 description 2
- 239000008101 lactose Substances 0.000 description 2
- 229940117841 methacrylic acid copolymer Drugs 0.000 description 2
- 229920003145 methacrylic acid copolymer Polymers 0.000 description 2
- 229920001223 polyethylene glycol Polymers 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000008107 starch Substances 0.000 description 2
- 235000019698 starch Nutrition 0.000 description 2
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 2
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- SMTDFMMXJHYDDE-UHFFFAOYSA-N 2-prop-1-enylpyridine Chemical compound CC=CC1=CC=CC=N1 SMTDFMMXJHYDDE-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- 239000004166 Lanolin Substances 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000021314 Palmitic acid Nutrition 0.000 description 1
- 235000019485 Safflower oil Nutrition 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 238000003915 air pollution Methods 0.000 description 1
- 239000003125 aqueous solvent Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000008199 coating composition Substances 0.000 description 1
- 239000003240 coconut oil Substances 0.000 description 1
- 235000019864 coconut oil Nutrition 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 239000001087 glyceryl triacetate Substances 0.000 description 1
- 235000013773 glyceryl triacetate Nutrition 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- 235000019388 lanolin Nutrition 0.000 description 1
- 229940039717 lanolin Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 235000021313 oleic acid Nutrition 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 229940093429 polyethylene glycol 6000 Drugs 0.000 description 1
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 description 1
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 1
- 229940068968 polysorbate 80 Drugs 0.000 description 1
- 229920000053 polysorbate 80 Polymers 0.000 description 1
- 239000003813 safflower oil Substances 0.000 description 1
- 235000005713 safflower oil Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000003826 tablet Substances 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 229960002622 triacetin Drugs 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
Landscapes
- Medicinal Preparation (AREA)
Description
【発明の詳細な説明】 本発明は腸溶性皮膜組成物に関する。[Detailed description of the invention] The present invention relates to enteric coating compositions.
従来、錠剤、丸剤、顆粒剤、細粒剤等の剤型を
有する薬剤に胃液に対する抵抗性をもたせ腸液で
速やかに溶解または崩壊させる目的で腸溶性皮膜
を施すことがしばしば行なわれている。その際、
使用される腸溶性皮膜形成剤としては、セルロー
ス アセテートフタレート(CAP)メチルビニ
ルピリジン・メチルアクリレート・メタクリル酸
共重合体(MPM)等が知られている。上記のよ
うな高分子物質類をコーテイングに用いるに際し
て一般に揮発性の有機溶媒に溶解してスプレーコ
ーテイングが行なわれる。この場合これらの有機
溶媒を捕捉する目的で排風を水洗する装置が必要
とされる。更にコーテイング作業場の環境保全の
ための空気調整機、電気器具類の防爆化等にも多
大な費用を要する上に、使用される溶媒のコスト
も無視できない。 Conventionally, enteric coatings have often been applied to drugs in the form of tablets, pills, granules, fine granules, etc. in order to make them resistant to gastric juices and to quickly dissolve or disintegrate them in intestinal fluids. that time,
Known enteric film forming agents used include cellulose acetate phthalate (CAP), methylvinylpyridine/methyl acrylate/methacrylic acid copolymer (MPM), and the like. When using the above polymeric substances for coating, spray coating is generally performed after dissolving them in a volatile organic solvent. In this case, a device for washing the exhaust air with water is required to capture these organic solvents. Furthermore, in order to protect the environment in the coating workshop, a large amount of cost is required to make air conditioners and electrical appliances explosion-proof, and the cost of the solvents used cannot be ignored.
以上のような問題点を解決する手段として水を
溶媒として用いることのできる腸溶性皮膜形成剤
が考えられ、すでにアクリル酸エチルとメタアク
リル酸の乳化重合で得た水分散性の共重合体を使
用することが知られている。この腸溶性皮膜形成
剤は可塑剤の添加が必要で可塑剤としてはポリエ
チレングリコール6000、ソルビタン脂肪酸エステ
ル、ポリソルベート80、トリアセチン等が良好で
あることは公知である。 Enteric film-forming agents that can use water as a solvent are considered as a means to solve the above problems, and water-dispersible copolymers obtained by emulsion polymerization of ethyl acrylate and methacrylic acid have already been used. known to use. This enteric film forming agent requires the addition of a plasticizer, and it is known that polyethylene glycol 6000, sorbitan fatty acid ester, polysorbate 80, triacetin, etc. are good plasticizers.
しかし上記可塑剤を使用してコーテイングを行
なう場合、被コーテイング物相互の固着がおこり
製品の品質及びコーテイング操作面で不都合であ
り且つ問題であつた。そこで本発明者は上記問題
点を解決すべく鋭意検討を重ねた結果、シヨ糖脂
肪酸エステルを添加すれば上記の欠点が効果的に
解決されるということを見い出し、本発明を完成
した。 However, when coating using the above-mentioned plasticizer, the objects to be coated stick to each other, which is inconvenient and problematic in terms of product quality and coating operation. As a result of intensive studies to solve the above-mentioned problems, the inventors of the present invention have discovered that the above-mentioned drawbacks can be effectively solved by adding sucrose fatty acid ester, and have completed the present invention.
即ち本発明はアクリル酸エチルとメタアクリル
酸の乳化重合で得た水分散性の共重合体とシヨ糖
脂肪酸エステルおよび水を主成分とすることを特
徴とする腸溶性皮膜組成物である。尚、必要に応
じ通常公知の可塑剤を併用することも出来る。 That is, the present invention is an enteric film composition characterized by containing as main components a water-dispersible copolymer obtained by emulsion polymerization of ethyl acrylate and methacrylic acid, sucrose fatty acid ester, and water. Incidentally, a commonly known plasticizer can also be used in combination, if necessary.
本発明において使用されるアクリル酸エチルと
メタアクリル酸の乳化重合で得た水分散性の共重
合体としてはたとえばオイドラギツト
L30D―
55(ロームフアーマ社、固形分の重量比30%を有
する水性分散液)が挙げられる。ここでいう乳化
重合とは、重合熱を分散し、重合反応を調節して
適当に進行させるため水を媒体に使用する重合反
応である。使用量は特に限定されないが懸濁液全
量の15.0〜70.0w/w%が適当であり、特に好ま
しくは30.0〜50.0w/w%である。 Examples of water-dispersible copolymers obtained by emulsion polymerization of ethyl acrylate and methacrylic acid used in the present invention include Eudragit L30D-
55 (Rohm Pharma, aqueous dispersion with a solids content of 30% by weight). The emulsion polymerization referred to herein is a polymerization reaction that uses water as a medium to disperse polymerization heat and control the polymerization reaction to proceed appropriately. Although the amount used is not particularly limited, it is suitably 15.0 to 70.0 w/w%, particularly preferably 30.0 to 50.0 w/w% of the total amount of the suspension.
また本発明において使用されるシヨ糖脂肪酸エ
ステルとしてはラウリン酸、ミリスチン酸、パル
ミチン酸、ステアリン酸、オレイン酸、リノール
酸などの高級脂肪酸のエステルあるいは牛脂、豚
脂、ラノリン、ヤシ油、ヒマシ油、サフラワー油
およびそれらの硬化油などの混合脂肪酸のエステ
ル等がありHLB6〜15のものが好ましい。本発明
方法によるシヨ糖脂肪酸エステルの使用量は特に
限定されないがオイドラギツト
L30D―55の0.5
〜5.0w/w%が適当であ、特に好ましくは1.0〜
4.0w/w%である。 Sucrose fatty acid esters used in the present invention include esters of higher fatty acids such as lauric acid, myristic acid, palmitic acid, stearic acid, oleic acid, and linoleic acid, beef tallow, lard, lanolin, coconut oil, castor oil, Esters of mixed fatty acids such as safflower oil and their hydrogenated oils are available, and those with HLB 6 to 15 are preferred. The amount of sucrose fatty acid ester used in the method of the present invention is not particularly limited, but is 0.5 of Eudragit L30D-55.
~5.0w/w% is appropriate, particularly preferably 1.0~
It is 4.0w/w%.
本組成物の調整方法としては精製水にシヨ糖脂
肪酸エステルを溶解または分散し、これにアクリ
ル酸エチルとメタアクリル酸の乳化重合で得た水
分散性の共重合体を添加混合する方法、あるいは
該共重合体にシヨ糖脂肪酸エステルを溶解または
分散し、水で希釈する方法等があるが、要はシヨ
糖脂肪酸エステル、該共重合体、水を組成物全量
の所定の割合で均な懸濁液になるように調整すれ
ばよく上記方法に限定されるものではない。 The present composition can be prepared by dissolving or dispersing sucrose fatty acid ester in purified water, and adding and mixing thereto a water-dispersible copolymer obtained by emulsion polymerization of ethyl acrylate and methacrylic acid; There are methods such as dissolving or dispersing the sucrose fatty acid ester in the copolymer and diluting it with water, but the key is to evenly distribute the sucrose fatty acid ester, the copolymer, and water in a predetermined proportion of the total amount of the composition. The method is not limited to the above method as long as it is adjusted to form a cloudy liquid.
以上のごとき本発明における腸溶性皮膜組成物
は一般の、粒子被覆がけ過程に従つて適用される
が本腸溶性皮膜組成物によれば胃液に対する抵抗
性を充分に備え、腸液には速やかに崩壊し、外観
が平滑かつ良好な被覆を施すことができる。さら
に通常水性溶媒被覆組成物を粒子にコーテイング
する場合、皮膜量が多くなるにつれて、粘着性が
増大し、粒子が互いにくつつき合い平滑な被覆を
形成することおよび被覆がけ作業を困難ならし
め、特に大量生産を殆んど不可能にする場合があ
るが、本腸溶性皮膜組成物はその欠陥を避けるこ
とができる。さらには本アクリル酸エチルとメタ
アクリル酸の乳化重合で得た水分散性の共重合体
の可塑剤として知られているポリエチレングリコ
ールを使用した場合と比較しても作業性は格段に
良好で平滑な被覆表面の顆粒を得ることができる
のも特長の一つである。また、水を溶媒として使
用するので有機溶媒を用いた場合の労働安全衛生
面における作業環境問題、大気汚染問題あるいは
医薬品に残留する溶媒規制等の色々の問題を解決
できるようになつたのも特徴の一つである。 The enteric coating composition of the present invention as described above is applied according to a general particle coating process, but the enteric coating composition of the present invention has sufficient resistance to gastric juices and quickly disintegrates in intestinal fluids. However, it is possible to provide a coating with a smooth and good appearance. Furthermore, when coating particles with an aqueous solvent coating composition, as the amount of coating increases, the tackiness increases and the particles tend to stick together, making it difficult to form a smooth coating and coating, especially in large quantities. Although it may make production almost impossible, the present enteric coating composition avoids that defect. Furthermore, workability is much better and smoother than when polyethylene glycol, which is known as a plasticizer for water-dispersible copolymers obtained by emulsion polymerization of ethyl acrylate and methacrylic acid, is used. One of the features is that it is possible to obtain granules with a uniformly coated surface. Another feature is that since water is used as a solvent, it has become possible to solve various problems when using organic solvents, such as work environment problems in terms of occupational safety and health, air pollution problems, and regulations on solvents remaining in pharmaceuticals. It is one.
以下に実施例を挙げて本発明を具体的に説明す
るが、本発明はこれによつて限定されるものでは
ない。 The present invention will be specifically described below with reference to Examples, but the present invention is not limited thereto.
実施例 1
(コーテイング液調製)
オイドラギツト
L30D―55(ロームフアーマ社
製) 50部
シヨ糖脂肪酸エステル(Dエステル
F―160
第一工業製薬) 1.8部
精製水 48.2部
上記組成比に従い、精製水にシヨ糖脂肪酸エス
テルを撹拌分散した後、オイドラギツト
L30D
―55を添加し撹拌混合しコーテイング液を精製し
た。得られたコーテイング液の分散状態は安定で
あつた。Example 1 (Coating liquid preparation) Eudragit L30D-55 (manufactured by Rohm Pharma) 50 parts sucrose fatty acid ester (D ester F-160)
Daiichi Kogyo Seiyaku) 1.8 parts Purified water 48.2 parts After stirring and dispersing sucrose fatty acid ester in purified water according to the above composition ratio, Eudragit L30D
-55 was added and mixed with stirring to purify the coating liquid. The dispersion state of the obtained coating liquid was stable.
(コーテイング)
乳糖・でん粉顆粒(重量比8:1)に上記コー
テイング液を用いてスプレーコーテイングを施し
た。コーテイング操作中顆粒のくつつきもみられ
ず平滑な被覆表面の顆粒を得た。 (Coating) Lactose/starch granules (weight ratio 8:1) were spray coated using the above coating liquid. No sticking of the granules was observed during the coating operation, and granules with a smooth coated surface were obtained.
得られた製剤の第9改正日本薬局方一般試験法
第33崩壊試験法の結果は下記の通りであつた。 The results of the 33rd disintegration test method of the 9th revised Japanese Pharmacopoeia General Test Methods for the obtained preparation were as follows.
第1液および第2液に対する崩壊性
第1液(PH1.2)…崩壊せず(1時間)
第2液(PH7.5)…10分〜15分
実施例 2
(コーテイング液調製)
シヨ糖脂肪酸エステル(DKエステル
F―50
第一工業製薬)1.5部を精製水48.5部に撹拌分散
し、これにオイドラギツト
L30―55 50部を添
加し、撹拌混合コーテイング液を調製した。 Disintegration properties for the 1st and 2nd liquids 1st liquid (PH1.2)...does not disintegrate (1 hour) 2nd liquid (PH7.5)...10 minutes to 15 minutes Example 2 (Coating liquid preparation) Cane sugar Fatty acid ester (DK ester F-50
Daiichi Kogyo Seiyaku) (1.5 parts) was stirred and dispersed in 48.5 parts of purified water, and 50 parts of Eudragit L30-55 was added thereto to prepare a stirring-mixed coating solution.
(コーテイング)
上記組成のコーテイング液を用いて実施例1の
場合と同一条件でコーテイングを実施し、顆粒の
くつつきも見られず平滑な被覆表面の顆粒を得る
ことができた。 (Coating) Coating was carried out under the same conditions as in Example 1 using the coating liquid having the above composition, and it was possible to obtain granules with a smooth coated surface without any granules being observed.
得られた製剤の第9改正日本薬局方一般試験法
第33崩壊試験法の結果は下記の通りであつた。 The results of the 33rd disintegration test method of the 9th revised Japanese Pharmacopoeia General Test Methods for the obtained preparation were as follows.
第1液および第2液に対する崩壊性
第1液(PH1.2)…崩壊せず(1時間)
第2液(PH7.5)…10〜15分
実施例 3
(コーテイング液調製)
シヨ糖脂肪酸エステル(DKエステル
F―
110第一工業製薬)1.0部を精製水73.6部に撹拌分
散し、これにオイドラギツト
L30D―55 25部を
添加し撹拌混合しコーテイング液を調製した。 Disintegration properties for the 1st and 2nd liquids 1st liquid (PH1.2)...no disintegration (1 hour) 2nd liquid (PH7.5)...10-15 minutes Example 3 (Coating liquid preparation) Sucrose fatty acid Ester (DK Ester F-
110 (Daiichi Kogyo Seiyaku) was stirred and dispersed in 73.6 parts of purified water, 25 parts of Eudragit L30D-55 was added and mixed with stirring to prepare a coating liquid.
(コーテイング)
上記組成のコーテイング液を用いて実施例1の
場合と同一条件でコーテイングを実施し、顆粒の
くつつきもみられず平滑な被覆表面の顆粒を得る
ことができた。 (Coating) Coating was carried out under the same conditions as in Example 1 using the coating liquid having the above composition, and it was possible to obtain granules with a smooth coated surface without any granules being observed.
得られた製剤の第9改正日本薬局方一般試験法
第33崩壊試験法の結果は下記の通りであつた。 The results of the 33rd disintegration test method of the 9th revised Japanese Pharmacopoeia General Test Methods for the obtained preparation were as follows.
第1液および第2液に対する崩壊性
第1液(PH1.2)…崩壊せず(1時間)
第2液(PH7.5)…10〜15分
実施例 4
(コーテイング液調製)
シヨ糖脂肪酸エステル(DKエステル
F―
140第一工業製薬)2.0部を精製水30.8部に撹拌分
散しこれにオイドラギツト
L30D―55、66.5部
を添加し撹拌混合しコーテイング液を調製した。 Disintegration properties for the 1st and 2nd liquids 1st liquid (PH1.2)...does not disintegrate (1 hour) 2nd liquid (PH7.5)...10-15 minutes Example 4 (Coating liquid preparation) Sucrose fatty acid Ester (DK Ester F-
140 (Daiichi Kogyo Seiyaku) was stirred and dispersed in 30.8 parts of purified water, 66.5 parts of Eudragit L30D-55 was added thereto, and mixed with stirring to prepare a coating liquid.
(コーテイング)
上記組成のコーテイング液を用いて実施例1の
場合と同一条件でコーテイングを実施し顆粒のく
つつきも見られず、平滑な被覆表面の顆粒を得る
ことができた。 (Coating) Coating was carried out under the same conditions as in Example 1 using a coating liquid having the above composition, and no granules were observed to be pebbled, and granules with a smooth coated surface could be obtained.
得られた製剤の第9改正日本薬局方一般試験法
第33崩壊試験法の結果は下記の通りであつた。 The results of the 33rd disintegration test method of the 9th revised Japanese Pharmacopoeia General Test Methods for the obtained preparation were as follows.
第1液および第2液に対する崩壊性
第1液(PH1.2)…崩壊せず(1時間)
第2液(PH7.5)…10〜15分
実施例 5
(コーテイング液調製)
シヨ糖脂肪酸エステル(DKエステル
F―
160第一工業製薬)1.8部を精製水48.2部に撹拌分
散しこれにオイドラギツト
L30D―55、50部を
添加し撹拌混合しコーテイング液を調製した。 Disintegration properties for the 1st and 2nd liquids 1st liquid (PH1.2)...no disintegration (1 hour) 2nd liquid (PH7.5)...10-15 minutes Example 5 (Coating liquid preparation) Sucrose fatty acid Ester (DK Ester F-
160 (Daiichi Kogyo Seiyaku) was stirred and dispersed in 48.2 parts of purified water, 50 parts of Eudragit L30D-55 was added thereto, and mixed with stirring to prepare a coating liquid.
(コーテイング)
乳糖・でん粉錠剤(250mg/1錠)に上記コー
テイング液を用いてスプレーコーテイングを施し
た。錠剤同士のくつつきも見られず平滑な被覆表
面の錠剤を得た。(Coating) Lactose/starch tablets (250 mg/tablet) were spray coated using the above coating solution. Tablets with a smooth coated surface were obtained, with no sticking between the tablets.
得られた製剤の第9改正日本薬局方一般試験法
第33崩壊試験法の結果は下記の通りであつた。 The results of the 33rd disintegration test method of the 9th revised Japanese Pharmacopoeia General Test Methods for the obtained preparation were as follows.
第1液および第2液に対する崩壊性
第1液(PH1.2)…崩壊せず(2時間)
第2液(PH7.5)…5〜10分
比較例 1
(コーテイング液調製)
ポリエチレングリコール(PEG1540)1.8部を
精製水48.2部に撹拌溶解しこれにオイドラギツト
L30D―55、50部を添加し撹拌混合しコーテイ
ング液を調製した。 Disintegration properties against the 1st and 2nd liquids 1st liquid (PH1.2)...no disintegration (2 hours) 2nd liquid (PH7.5)...5 to 10 minutes Comparative Example 1 (Coating liquid preparation) Polyethylene glycol ( Stir and dissolve 1.8 parts of PEG1540) in 48.2 parts of purified water and add Eudragit to this.
50 parts of L30D-55 was added and mixed with stirring to prepare a coating liquid.
(コーテイング)
上記組成のコーテイング液を用いて実施例1の
場合と同一条件でコーテイングを実施したが、コ
ーテイング時に顆粒のくつつきが顕著で平滑な被
覆表面の顆粒を得ることが困難であつた。 (Coating) Coating was carried out under the same conditions as in Example 1 using a coating liquid having the above composition, but the granules were noticeably scratched during coating and it was difficult to obtain granules with a smooth coated surface.
得られた製剤の第9改正日本薬局方一般試験法
第33崩壊試験法の結果は下記の通りであつた。 The results of the 33rd disintegration test method of the 9th revised Japanese Pharmacopoeia General Test Methods for the obtained preparation were as follows.
第1液および第2液に対する崩壊性
第1液(PH1.2)…膨潤及び若干崩壊(1時
間)
第2液(PH7.5)…崩壊せず(30分) Disintegration properties for the 1st and 2nd liquids 1st liquid (PH1.2)...swells and slightly disintegrates (1 hour) 2nd liquid (PH7.5)...does not disintegrate (30 minutes)
Claims (1)
合で得た水分散性の共重合体とシヨ糖脂肪酸エス
テルおよび水を主成分とすることを特徴とする腸
溶性皮膜組成物。 2 シヨ糖脂肪酸エステルのHLBが6〜15であ
る特許請求の範囲第1項記載の腸溶性皮膜組成
物。[Scope of Claims] 1. An enteric film composition characterized by containing as main components a water-dispersible copolymer obtained by emulsion polymerization of ethyl acrylate and methacrylic acid, a sucrose fatty acid ester, and water. 2. The enteric coating composition according to claim 1, wherein the HLB of the sucrose fatty acid ester is 6 to 15.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5485281A JPS57169427A (en) | 1981-04-10 | 1981-04-10 | Enteric coating composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP5485281A JPS57169427A (en) | 1981-04-10 | 1981-04-10 | Enteric coating composition |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS57169427A JPS57169427A (en) | 1982-10-19 |
JPH0250885B2 true JPH0250885B2 (en) | 1990-11-05 |
Family
ID=12982117
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP5485281A Granted JPS57169427A (en) | 1981-04-10 | 1981-04-10 | Enteric coating composition |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS57169427A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0268332U (en) * | 1988-11-10 | 1990-05-23 |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5877825A (en) * | 1981-11-05 | 1983-05-11 | Eisai Co Ltd | Enteric solid pharmaceutical preparation |
JPS6216432A (en) * | 1985-07-05 | 1987-01-24 | Shin Etsu Chem Co Ltd | Enteric coating composition |
DE3920082A1 (en) * | 1989-06-20 | 1991-03-07 | Roehm Gmbh | FILM-FORMING AQUEOUS COATING AGENT FOR SOLID MEDICINAL PRODUCTS, METHOD FOR THE PRODUCTION AND USE THEREOF |
TW200633731A (en) * | 2004-12-06 | 2006-10-01 | Freund Corp | Film coating composition, and coating and tablet of the composition |
-
1981
- 1981-04-10 JP JP5485281A patent/JPS57169427A/en active Granted
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH0268332U (en) * | 1988-11-10 | 1990-05-23 |
Also Published As
Publication number | Publication date |
---|---|
JPS57169427A (en) | 1982-10-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA1199869A (en) | Preparation of aqueous alcoholic dispersions of ph sensitive polymers and plasticizing agents and a method of enteric coating dosage forms using same | |
US3909444A (en) | Microcapsule | |
US4518433A (en) | Enteric coating for pharmaceutical dosage forms | |
US4775536A (en) | Enteric coated tablet and process for making | |
US4683256A (en) | Dry edible film coating composition, method and coating form | |
US3935326A (en) | Process for coating tablets with aqueous resin dispersions | |
US4060598A (en) | Tablets coated with aqueous resin dispersions | |
US4287221A (en) | Method for providing enteric coating on solid dosage forms | |
JPS61100527A (en) | Film-formable medicinal coating agent aqueous dispersion andmanufacture | |
DE3405378A1 (en) | MEDICINE COVER | |
EP0108504B1 (en) | A process for coating solid pharmaceutical preparations and coated preparations thus obtained | |
EP0035780A1 (en) | Coating compositions for enterosoluble solid dosage forms | |
KR20080074083A (en) | Solid formulation for medicine comprising sparingly soluble drug and process for preparing the same | |
JPH0250885B2 (en) | ||
JPH08245423A (en) | Aqueous enteric coating solution | |
CA1236024A (en) | Enteric coating liquid | |
JP2960482B2 (en) | Film-forming aqueous coating for solid pharmaceutical forms, process for producing the same and method for coating pharmaceutical forms | |
JPH0138091B2 (en) | ||
JP2925346B2 (en) | Enteric-coated preparation and its production method | |
Kane et al. | Technological evaluation of three enteric coating polymers I. with an insoluble drug | |
DE4341156C2 (en) | Use of water-redispersible plastic dispersion powders as drug carriers | |
JPH08333238A (en) | Enteric coated preparation coated by solventless enteric coating agent using liquid wax | |
JPH0559098B2 (en) | ||
US4456628A (en) | Process for film-coating a particulate solid, and emulsions for conducting the process | |
JPH0238568B2 (en) | ABURARUIOKUWAETENARUAKYUASUKOOCHINGUHO |